Christopher Ryan Sullivan

Insider Reports History

Entity
Individual
Location
C/O Cerecor Inc., 400 E. Pratt Street, Suite 606, Baltimore, MD
Signature
/s/ Donald R. Reynolds, by Power of Attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher Ryan Sullivan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Avalo Therapeutics, Inc. Chief Financial Officer Restricted Stock Units 48.4K $409K $8.46 Mar 28, 2025 Direct
Avalo Therapeutics, Inc. Chief Financial Officer Common Stock 16.9K $143K $8.46 Mar 28, 2025 Direct
Avalo Therapeutics, Inc. Chief Financial Officer Stock Option (Right to Buy) 163K Jan 28, 2025 Direct

Insider Reports Filed by Christopher Ryan Sullivan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AVTX Avalo Therapeutics, Inc. Mar 28, 2025 3 -$61.6K 4 Apr 1, 2025 Chief Financial Officer
AVTX Avalo Therapeutics, Inc. Jan 28, 2025 1 $0 4 Jan 30, 2025 Chief Financial Officer
AVTX Avalo Therapeutics, Inc. Aug 13, 2024 2 $0 4 Aug 14, 2024 Chief Financial Officer
AVTX Avalo Therapeutics, Inc. Jun 9, 2023 1 $1.75K 4 Jun 13, 2023 Chief Financial Officer
AVTX Avalo Therapeutics, Inc. May 15, 2023 1 $0 4 May 17, 2023 Chief Financial Officer
AVTX Avalo Therapeutics, Inc. Feb 13, 2023 1 $0 4 Feb 15, 2023 Chief Financial Officer
AVTX Avalo Therapeutics, Inc. Oct 5, 2022 1 $0 4 Oct 7, 2022 Chief Financial Officer
AVTX Avalo Therapeutics, Inc. Mar 8, 2022 2 $0 4 Mar 10, 2022 Chief Financial Officer
AVTX Avalo Therapeutics, Inc. Dec 10, 2021 1 $1.5K 4 Dec 14, 2021 Chief Accounting Officer